ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pet Cancer Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-35N13058
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pet Cancer Therapeutics Market Research Report 2023
BUY CHAPTERS

Pet Cancer Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35N13058
Report
September 2024
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aratana Therapeutics Inc
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc
VetDC, Inc
Karyopharm Therapeutics Inc
Rhizen Pharmaceutical SA
Regeneus
Oasmia Pharmaceuticals AB
Zoetis Inc
Elanco
Merial 
ELIAS Animal Health
VetiVax
Ngelheim International GmbH

Pet Cancer Therapeutics - Market Size

The global market for Pet Cancer Therapeutics was estimated to be worth US$ 396.2 million in 2023 and is forecast to a readjusted size of US$ 675.4 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030

Pet Cancer Therapeutics - Market

Pet Cancer Therapeutics - Market

Pet cancer therapeutics are the novel drug molecules that exhibit high potential to reduce the effects of cancer, giving access to comprehensive cancer care with minimum side effects. Cancer therapies aims to permanently eradicate the cancerous cells prevalent in pets. The veterinarian recommends specific treatment program such as targeted therapy and combination therapy or chemotherapy depending on the type of cancer, stage, and nature of the cancer.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet Cancer Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pet Cancer Therapeutics by region & country, by Type, and by Application.
The Pet Cancer Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Cancer Therapeutics.
Market Segmentation

Scope of Pet Cancer Therapeutics - Market Report

Report Metric Details
Report Name Pet Cancer Therapeutics - Market
Forecasted market size in 2030 US$ 675.4 million
CAGR 7.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Chemotherapy
  • Targeted Therapy
  • Combination Therapy
  • Immunotherapy
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aratana Therapeutics, Inc, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc, VetDC, Inc, Karyopharm Therapeutics, Inc, Rhizen Pharmaceutical SA, Regeneus Ltd., Oasmia Pharmaceuticals AB, Zoetis, VetiVax, Ngelheim International GmbH, Elanco, Merial Inc, ELIAS Animal Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pet Cancer Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Pet Cancer Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Pet Cancer Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pet Cancer Therapeutics - Market size in 2030?

Ans: The Pet Cancer Therapeutics - Market size in 2030 will be US$ 675.4 million.

What is the Pet Cancer Therapeutics - Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Pet Cancer Therapeutics - Market report?

Ans: The main players in the Pet Cancer Therapeutics - Market are Aratana Therapeutics, Inc, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc, VetDC, Inc, Karyopharm Therapeutics, Inc, Rhizen Pharmaceutical SA, Regeneus Ltd., Oasmia Pharmaceuticals AB, Zoetis, VetiVax, Ngelheim International GmbH, Elanco, Merial Inc, ELIAS Animal Health

What are the Application segmentation covered in the Pet Cancer Therapeutics - Market report?

Ans: The Applications covered in the Pet Cancer Therapeutics - Market report are Lymphoma, Mast Cell Cancer, Melanoma, Mammary, Squamous Cell Cancer, Others

What are the Type segmentation covered in the Pet Cancer Therapeutics - Market report?

Ans: The Types covered in the Pet Cancer Therapeutics - Market report are Chemotherapy, Targeted Therapy, Combination Therapy, Immunotherapy

Recommended Reports

Pet Nutrition

Veterinary Devices

Pet Health Products

1 Market Overview
1.1 Pet Cancer Therapeutics Product Introduction
1.2 Global Pet Cancer Therapeutics Market Size Forecast
1.3 Pet Cancer Therapeutics Market Trends & Drivers
1.3.1 Pet Cancer Therapeutics Industry Trends
1.3.2 Pet Cancer Therapeutics Market Drivers & Opportunity
1.3.3 Pet Cancer Therapeutics Market Challenges
1.3.4 Pet Cancer Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pet Cancer Therapeutics Players Revenue Ranking (2023)
2.2 Global Pet Cancer Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Pet Cancer Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pet Cancer Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Pet Cancer Therapeutics
2.6 Pet Cancer Therapeutics Market Competitive Analysis
2.6.1 Pet Cancer Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pet Cancer Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Cancer Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemotherapy
3.1.2 Targeted Therapy
3.1.3 Combination Therapy
3.1.4 Immunotherapy
3.2 Global Pet Cancer Therapeutics Sales Value by Type
3.2.1 Global Pet Cancer Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pet Cancer Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Pet Cancer Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Lymphoma
4.1.2 Mast Cell Cancer
4.1.3 Melanoma
4.1.4 Mammary
4.1.5 Squamous Cell Cancer
4.1.6 Others
4.2 Global Pet Cancer Therapeutics Sales Value by Application
4.2.1 Global Pet Cancer Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pet Cancer Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Pet Cancer Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pet Cancer Therapeutics Sales Value by Region
5.1.1 Global Pet Cancer Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pet Cancer Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Pet Cancer Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Pet Cancer Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pet Cancer Therapeutics Sales Value, 2019-2030
5.2.2 North America Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pet Cancer Therapeutics Sales Value, 2019-2030
5.3.2 Europe Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pet Cancer Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pet Cancer Therapeutics Sales Value, 2019-2030
5.5.2 South America Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pet Cancer Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pet Cancer Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pet Cancer Therapeutics Sales Value
6.3 United States
6.3.1 United States Pet Cancer Therapeutics Sales Value, 2019-2030
6.3.2 United States Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pet Cancer Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pet Cancer Therapeutics Sales Value, 2019-2030
6.4.2 Europe Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pet Cancer Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pet Cancer Therapeutics Sales Value, 2019-2030
6.5.2 China Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pet Cancer Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pet Cancer Therapeutics Sales Value, 2019-2030
6.6.2 Japan Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pet Cancer Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pet Cancer Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pet Cancer Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pet Cancer Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pet Cancer Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pet Cancer Therapeutics Sales Value, 2019-2030
6.9.2 India Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pet Cancer Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aratana Therapeutics, Inc
7.1.1 Aratana Therapeutics, Inc Profile
7.1.2 Aratana Therapeutics, Inc Main Business
7.1.3 Aratana Therapeutics, Inc Pet Cancer Therapeutics Products, Services and Solutions
7.1.4 Aratana Therapeutics, Inc Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Aratana Therapeutics, Inc Recent Developments
7.2 AB Science
7.2.1 AB Science Profile
7.2.2 AB Science Main Business
7.2.3 AB Science Pet Cancer Therapeutics Products, Services and Solutions
7.2.4 AB Science Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 AB Science Recent Developments
7.3 Boehringer Ingelheim International GmbH
7.3.1 Boehringer Ingelheim International GmbH Profile
7.3.2 Boehringer Ingelheim International GmbH Main Business
7.3.3 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Products, Services and Solutions
7.3.4 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Zenoaq Recent Developments
7.4 Zenoaq
7.4.1 Zenoaq Profile
7.4.2 Zenoaq Main Business
7.4.3 Zenoaq Pet Cancer Therapeutics Products, Services and Solutions
7.4.4 Zenoaq Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Zenoaq Recent Developments
7.5 Morphogenesis, Inc
7.5.1 Morphogenesis, Inc Profile
7.5.2 Morphogenesis, Inc Main Business
7.5.3 Morphogenesis, Inc Pet Cancer Therapeutics Products, Services and Solutions
7.5.4 Morphogenesis, Inc Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Morphogenesis, Inc Recent Developments
7.6 VetDC, Inc
7.6.1 VetDC, Inc Profile
7.6.2 VetDC, Inc Main Business
7.6.3 VetDC, Inc Pet Cancer Therapeutics Products, Services and Solutions
7.6.4 VetDC, Inc Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 VetDC, Inc Recent Developments
7.7 Karyopharm Therapeutics, Inc
7.7.1 Karyopharm Therapeutics, Inc Profile
7.7.2 Karyopharm Therapeutics, Inc Main Business
7.7.3 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Products, Services and Solutions
7.7.4 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Karyopharm Therapeutics, Inc Recent Developments
7.8 Rhizen Pharmaceutical SA
7.8.1 Rhizen Pharmaceutical SA Profile
7.8.2 Rhizen Pharmaceutical SA Main Business
7.8.3 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Products, Services and Solutions
7.8.4 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 Rhizen Pharmaceutical SA Recent Developments
7.9 Regeneus Ltd.
7.9.1 Regeneus Ltd. Profile
7.9.2 Regeneus Ltd. Main Business
7.9.3 Regeneus Ltd. Pet Cancer Therapeutics Products, Services and Solutions
7.9.4 Regeneus Ltd. Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Regeneus Ltd. Recent Developments
7.10 Oasmia Pharmaceuticals AB
7.10.1 Oasmia Pharmaceuticals AB Profile
7.10.2 Oasmia Pharmaceuticals AB Main Business
7.10.3 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Products, Services and Solutions
7.10.4 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Oasmia Pharmaceuticals AB Recent Developments
7.11 Zoetis
7.11.1 Zoetis Profile
7.11.2 Zoetis Main Business
7.11.3 Zoetis Pet Cancer Therapeutics Products, Services and Solutions
7.11.4 Zoetis Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Zoetis Recent Developments
7.12 VetiVax
7.12.1 VetiVax Profile
7.12.2 VetiVax Main Business
7.12.3 VetiVax Pet Cancer Therapeutics Products, Services and Solutions
7.12.4 VetiVax Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 VetiVax Recent Developments
7.13 Ngelheim International GmbH
7.13.1 Ngelheim International GmbH Profile
7.13.2 Ngelheim International GmbH Main Business
7.13.3 Ngelheim International GmbH Pet Cancer Therapeutics Products, Services and Solutions
7.13.4 Ngelheim International GmbH Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Ngelheim International GmbH Recent Developments
7.14 Elanco
7.14.1 Elanco Profile
7.14.2 Elanco Main Business
7.14.3 Elanco Pet Cancer Therapeutics Products, Services and Solutions
7.14.4 Elanco Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Elanco Recent Developments
7.15 Merial Inc
7.15.1 Merial Inc Profile
7.15.2 Merial Inc Main Business
7.15.3 Merial Inc Pet Cancer Therapeutics Products, Services and Solutions
7.15.4 Merial Inc Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 Merial Inc Recent Developments
7.16 ELIAS Animal Health
7.16.1 ELIAS Animal Health Profile
7.16.2 ELIAS Animal Health Main Business
7.16.3 ELIAS Animal Health Pet Cancer Therapeutics Products, Services and Solutions
7.16.4 ELIAS Animal Health Pet Cancer Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 ELIAS Animal Health Recent Developments
8 Industry Chain Analysis
8.1 Pet Cancer Therapeutics Industrial Chain
8.2 Pet Cancer Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pet Cancer Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Pet Cancer Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Aratana Therapeutics Inc
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc
VetDC, Inc
Karyopharm Therapeutics Inc
Rhizen Pharmaceutical SA
Regeneus
Oasmia Pharmaceuticals AB
Zoetis Inc
Elanco
Merial 
ELIAS Animal Health
VetiVax
Ngelheim International GmbH
List of Tables
    Table 1. Pet Cancer Therapeutics Market Trends
    Table 2. Pet Cancer Therapeutics Market Drivers & Opportunity
    Table 3. Pet Cancer Therapeutics Market Challenges
    Table 4. Pet Cancer Therapeutics Market Restraints
    Table 5. Global Pet Cancer Therapeutics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pet Cancer Therapeutics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Pet Cancer Therapeutics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Pet Cancer Therapeutics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Pet Cancer Therapeutics
    Table 10. Global Pet Cancer Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Cancer Therapeutics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Pet Cancer Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Pet Cancer Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Pet Cancer Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Pet Cancer Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Pet Cancer Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Pet Cancer Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Pet Cancer Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Pet Cancer Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Pet Cancer Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Pet Cancer Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Pet Cancer Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Pet Cancer Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Pet Cancer Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Pet Cancer Therapeutics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Pet Cancer Therapeutics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Pet Cancer Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Pet Cancer Therapeutics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Pet Cancer Therapeutics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Aratana Therapeutics, Inc Basic Information List
    Table 32. Aratana Therapeutics, Inc Description and Business Overview
    Table 33. Aratana Therapeutics, Inc Pet Cancer Therapeutics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Aratana Therapeutics, Inc (2019-2024)
    Table 35. Aratana Therapeutics, Inc Recent Developments
    Table 36. AB Science Basic Information List
    Table 37. AB Science Description and Business Overview
    Table 38. AB Science Pet Cancer Therapeutics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Pet Cancer Therapeutics Business of AB Science (2019-2024)
    Table 40. AB Science Recent Developments
    Table 41. Boehringer Ingelheim International GmbH Basic Information List
    Table 42. Boehringer Ingelheim International GmbH Description and Business Overview
    Table 43. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Boehringer Ingelheim International GmbH (2019-2024)
    Table 45. Boehringer Ingelheim International GmbH Recent Developments
    Table 46. Zenoaq Basic Information List
    Table 47. Zenoaq Description and Business Overview
    Table 48. Zenoaq Pet Cancer Therapeutics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Zenoaq (2019-2024)
    Table 50. Zenoaq Recent Developments
    Table 51. Morphogenesis, Inc Basic Information List
    Table 52. Morphogenesis, Inc Description and Business Overview
    Table 53. Morphogenesis, Inc Pet Cancer Therapeutics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Morphogenesis, Inc (2019-2024)
    Table 55. Morphogenesis, Inc Recent Developments
    Table 56. VetDC, Inc Basic Information List
    Table 57. VetDC, Inc Description and Business Overview
    Table 58. VetDC, Inc Pet Cancer Therapeutics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Pet Cancer Therapeutics Business of VetDC, Inc (2019-2024)
    Table 60. VetDC, Inc Recent Developments
    Table 61. Karyopharm Therapeutics, Inc Basic Information List
    Table 62. Karyopharm Therapeutics, Inc Description and Business Overview
    Table 63. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Karyopharm Therapeutics, Inc (2019-2024)
    Table 65. Karyopharm Therapeutics, Inc Recent Developments
    Table 66. Rhizen Pharmaceutical SA Basic Information List
    Table 67. Rhizen Pharmaceutical SA Description and Business Overview
    Table 68. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Rhizen Pharmaceutical SA (2019-2024)
    Table 70. Rhizen Pharmaceutical SA Recent Developments
    Table 71. Regeneus Ltd. Basic Information List
    Table 72. Regeneus Ltd. Description and Business Overview
    Table 73. Regeneus Ltd. Pet Cancer Therapeutics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Regeneus Ltd. (2019-2024)
    Table 75. Regeneus Ltd. Recent Developments
    Table 76. Oasmia Pharmaceuticals AB Basic Information List
    Table 77. Oasmia Pharmaceuticals AB Description and Business Overview
    Table 78. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Oasmia Pharmaceuticals AB (2019-2024)
    Table 80. Oasmia Pharmaceuticals AB Recent Developments
    Table 81. Zoetis Basic Information List
    Table 82. Zoetis Description and Business Overview
    Table 83. Zoetis Pet Cancer Therapeutics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Zoetis (2019-2024)
    Table 85. Zoetis Recent Developments
    Table 86. VetiVax Basic Information List
    Table 87. VetiVax Description and Business Overview
    Table 88. VetiVax Pet Cancer Therapeutics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Pet Cancer Therapeutics Business of VetiVax (2019-2024)
    Table 90. VetiVax Recent Developments
    Table 91. Ngelheim International GmbH Basic Information List
    Table 92. Ngelheim International GmbH Description and Business Overview
    Table 93. Ngelheim International GmbH Pet Cancer Therapeutics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Ngelheim International GmbH (2019-2024)
    Table 95. Ngelheim International GmbH Recent Developments
    Table 96. Elanco Basic Information List
    Table 97. Elanco Description and Business Overview
    Table 98. Elanco Pet Cancer Therapeutics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Elanco (2019-2024)
    Table 100. Elanco Recent Developments
    Table 101. Merial Inc Basic Information List
    Table 102. Merial Inc Description and Business Overview
    Table 103. Merial Inc Pet Cancer Therapeutics Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Pet Cancer Therapeutics Business of Merial Inc (2019-2024)
    Table 105. Merial Inc Recent Developments
    Table 106. ELIAS Animal Health Basic Information List
    Table 107. ELIAS Animal Health Description and Business Overview
    Table 108. ELIAS Animal Health Pet Cancer Therapeutics Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Pet Cancer Therapeutics Business of ELIAS Animal Health (2019-2024)
    Table 110. ELIAS Animal Health Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Pet Cancer Therapeutics Downstream Customers
    Table 114. Pet Cancer Therapeutics Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Pet Cancer Therapeutics Product Picture
    Figure 2. Global Pet Cancer Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pet Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Pet Cancer Therapeutics Report Years Considered
    Figure 5. Global Pet Cancer Therapeutics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pet Cancer Therapeutics Revenue in 2023
    Figure 7. Pet Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Chemotherapy Picture
    Figure 9. Targeted Therapy Picture
    Figure 10. Combination Therapy Picture
    Figure 11. Immunotherapy Picture
    Figure 12. Global Pet Cancer Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Pet Cancer Therapeutics Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Lymphoma
    Figure 15. Product Picture of Mast Cell Cancer
    Figure 16. Product Picture of Melanoma
    Figure 17. Product Picture of Mammary
    Figure 18. Product Picture of Squamous Cell Cancer
    Figure 19. Product Picture of Others
    Figure 20. Global Pet Cancer Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Pet Cancer Therapeutics Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America Pet Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe Pet Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific Pet Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America Pet Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa Pet Cancer Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa Pet Cancer Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions Pet Cancer Therapeutics Sales Value (%), (2019-2030)
    Figure 33. United States Pet Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States Pet Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe Pet Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe Pet Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 39. China Pet Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 41. China Pet Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan Pet Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan Pet Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea Pet Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea Pet Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia Pet Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia Pet Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 51. India Pet Cancer Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India Pet Cancer Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 53. India Pet Cancer Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 54. Pet Cancer Therapeutics Industrial Chain
    Figure 55. Pet Cancer Therapeutics Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Pet Veterinary Drug Market Insights Forecast to 2030
Molecular Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pet Cancer Targeted Drug Market Research Report 2024
Global Pet Pharmaceuticals Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Veterinary Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Cancer Therapy Market Research Report 2024
Global Small Companion Animal Drug Market Research Report 2024
Pet Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Preventive Medicine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Oncology Drugs Market Research Report 2024
Antimicrobials for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pet Antibiotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pet Therapeutics Market Research Report 2025
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Cancer Treatment Drugs Market
Pet Drug and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pet Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Targeted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti inflammatory Medicine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions